Company Search:
Advanced Search
Sponsored Links
Sopharma Trading AD Company Snapshot
Sopharma Trading AD operates in the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sopharma Trading AD with three other drug stores in Europe: Medios AG of GERMANY (2020 sales of 626.54 million Euros [US$750.35 million] of which 90% was SPECIALTY-PHARMA TRADE), Clinigen Group PLC of UNITED KINGDOM (£504.30 million [US$694.63 million] of which 39% was Unlicensed Medicines), and Medika d.d. which is based in CROATIA (3.99 billion Croatian Kunas [US$631.27 million] ).

Sales Analysis. Sopharma Trading AD reported sales of 1.17 billion Bulgarian Levas (US$713.69 million) for the year ending December of 2020. This represents an increase of 21.6% versus 2019, when the company's sales were 958.69 million Bulgarian Levas. Sales at Sopharma Trading AD have increased during each of the previous five years (and since 2015, sales have increased a total of 91%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sopharma Trading AD
  Stock Performance Chart for Sopharma Trading AD
  Stock Data: Recent Stock Performance:
  Current Price (4/9/2021): 5.65
(Figures in Bulgarian Levas)
1 Week -1.7%   13 Weeks -2.6%  
4 Weeks -0.9%   52 Weeks 7.6%  
Sopharma Trading AD Key Data:
  Ticker: SFT Country: Bulgaria
  Exchanges: BGR Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2020 Sales 1,165,461,000
(Year Ending Jan 2021).
Employees: 699
  Currency: Bulgarian Levas Market Cap: 193,659,683
  Fiscal Yr Ends: December Shares Outstanding: 34,276,050
  Share Type: Closely Held Shares: 27,223,752
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.